- ISO 17025 lab-tested
- 99%+ purity
- Research use only
Retatrutide
-
Processed as soon as payment clears
Packed and dispatched without delay.
-
Free shipping over €99.00 to most EU countries
-
Shipment protection included
Lost or damaged in transit? We send a replacement.
-
Discreet packaging
Plain parcel, no product names on the outside.
-
We accept
Secure checkout
- SEPA bank transfer
Independent lab results
Tested before it reaches your bench
Every batch is analysed by an independent, ISO 17025-accredited laboratory before release. The report shown here belongs to the batch now shipping, so what you read is what you receive.
Janoshik Analytical
ISO/IEC 17025 accredited
HPLC purity
99.8%
Release minimum: 99%
- Lot
- RT10/10100
- Tested
- October 2, 2026
- Measured
- 10.09 mg
- Report no.
- #237784
- Size tested
- 10mg
- Batch-specific
- Independent lab
Quality control results
2 passed · 2 reported-
Purity
Reversed-phase HPLC
99.8% Pass -
Net peptide content
HPLC quantitation
10.09 mg Reported -
Heavy metals
Elemental analysis · As, Cd, Pb, Hg
Not detected Pass -
Endotoxin
Endotoxin assay
<1 EU/vial Reported
Tests in our panel
- Visual inspection · Colour, form and integrity of the lyophilised powder and the vial seal, checked against the specification.
- LC-MS · Confirms the molecular mass matches the expected structure of the compound.
- Impurity profile · Checks for residues from synthesis and handling that should not be present.
- Microbial culture · Checks a sample for bacterial and fungal growth.
All published batches
Every lot of this product we have released, each with its own certificate. Newest first.
Retatrutide
LatestLOT RT10/10100
99.8%
HPLC purity
- Measured content
- 10.09 mg
- Heavy metals
- Not detected
- Endotoxin
- <1 EU/vial
- Tested on
- October 2, 2026
7 assays by Janoshik Analytical
Reports in this lot
Technical specifications
Compound at a glance
Molecular profile
Retatrutide
- Compound class
- GLP-1 / GIP / glucagon triple receptor agonist
- CAS number
- 2381089-83-2
- Molecular weight
- 4,731 Da
- Molecular formula
- C226H352N60O68S
- Amino acids
- 39 amino acids
- Reported half-life
- ~6 days (fatty-acid modified)
- Research area
- Energy balance & metabolic research
Handling
Storage and stability
- −20 °C as powder
- 2–8 °C in solution
- Protect from light
- Keep dry
Lyophilised powder
−20 °C, protected from light and moisture
In solution
2 to 8 °C
General guidance for laboratory storage. Follow your institution’s handling procedures.
About this compound
Retatrutide – Multi-Receptor Peptide for Metabolic & Weight Management
- Composition: Retatrutide (lyophilized peptide powder)
- Category: Peptide
- Form: Vial with freeze-dried powder
What is Retatrutide?
Retatrutide is an advanced, long-acting triple agonist peptide that simultaneously activates the GLP-1 (Glucagon-Like Peptide-1), GIP (Glucose-Dependent Insulinotropic Polypeptide), and Glucagon receptors.
It belongs to a new generation of metabolic research peptides designed to increase energy expenditure, regulate appetite, and improve glucose and lipid metabolism.
Through the simultaneous activation of multiple metabolic pathways, Retatrutide has shown remarkable potential in preclinical and clinical studies investigating obesity, insulin resistance, and metabolic disorders.
Ideal for energy balance, weight regulation, and peptide-based metabolic modulation.
Key Research Findings
Triple Receptor Activation: Simultaneous stimulation of GLP-1, GIP, and Glucagon receptors for enhanced metabolic efficiency.
Appetite & Energy Regulation: Influences central mechanisms of appetite control and promotes caloric expenditure.
Glucose & Lipid Metabolism: Supports improved insulin sensitivity, glucose homeostasis, and fat oxidation.
Body Composition: Studied for its potential to reduce body fat while preserving lean mass.
Storage Instructions
- Store at 2–8 °C (36–46 °F)
- Protect from light and moisture
- Do not freeze
- Avoid temperature fluctuations
Why Choose Retatrutide?
Retatrutide is one of the most advanced multi-agonist peptides currently under investigation.
Through its synergistic activation of GLP-1, GIP, and Glucagon receptors, it provides unique insights into the hormonal regulation of energy balance, fat metabolism, and appetite control.
Order Retatrutide and explore its potential in the next generation of metabolic and weight management research.
Research notice
For laboratory research use only. This product is not a medicinal product or a food. It is not intended for human or veterinary use, or for any diagnostic or therapeutic purpose.
The buyer is responsible for receiving, storing, handling and disposing of this material safely and lawfully, in line with the rules of their country and institution. We sell only to adults aged 18 or over who are qualified to work with research materials.
Descriptions on this page summarise published research for educational purposes. They are not medical advice and make no claim about safety or effects in humans.
